3BlateauO, Jeannot E, Bioulac-Sage P, etal. Bi-allelic inactivation of TCF1 in hepatic adenomas[J]. Nat Genet, 2002,32(2): 312-315.
4Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC [ J ]. Hepatoiogy, 2006,43(3):515-524.
5Bioulae-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenomas subtype classification using molecular markers and immunohistochemistry [ J ]. Hepatology, 2007,46(3):740-748.
6Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical; morphologic, and molecular features defining so-called telaagiectatic focal nodular hyperplasias ff the liver [J]. Gastroenterology, 2005, 128(5):1211-1218.
7Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma [J]. Gastroenterology, 2004,126(5): 1323-1329.
8Ichikawa T, FederleMP, Grazioli L, et al. Hegatocellular adenoma: muhiphasic CT and histapathologic findings in 25 patients [J]. Radiology, 2000, 214 (3) : 861-868.
9van den Esschert JW, van Gulik TM, Phoa SS. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma [J ]. Dig Surg, 2010,27(1):46-55.
10van den Esschert JW, Bieze M, Beuers UH, et al. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT [J]. Eur J Nucl Mol Imaging,2010, 18: published online.
